Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

106.25
+0.90000.85%
Volume:477.84K
Turnover:50.46M
Market Cap:12.06B
PE:31.42
High:106.46
Open:104.47
Low:103.47
Close:105.35
52wk High:109.66
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.32
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:84.01
PE(LYR):41.50

Loading ...

Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities